What is the Fiscal Year for Unicycive Therapeutics?
Date: November 14, 2026
Unicycive Therapeutics's current fiscal year starts on January 1, 2026, and ends on December 31, 2026. Their current quarter is Q4, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2026
Fiscal Year End
December 31, 2026
Current Quarter
Q4
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jan 1, 2026 – Mar 31, 2026
Q2
Apr 1, 2026 – Jun 30, 2026
Q3
Jul 1, 2026 – Sep 30, 2026
Q4
Oct 1, 2026 – Dec 31, 2026
Company Information
Headquarters
Los Altos, CA
Industry
Biotechnology Research
Stock Symbol
UNCY
Website
https://unicycive.comDescription
Unicycive Therapeutics was founded to identify overlooked opportunities in healthcare and turn them into life-changing medicines for patients in need. With a best-in-class team and a fearless approach to innovation, we move with speed and efficiency — because patients can’t afford to wait. Advancing a clinical-stage pipeline led by Oxylanthanum Carbonate (OLC), an investigational phosphate binder for chronic kidney disease (CKD).
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Unicycive Therapeutics and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.